Drugs / phenanthrene
phenanthrene
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT03631667 | Oct 2018 → Jan 2024 | exposure, dental pulp | Oregon State University | Completed | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | phenanthrene | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03631667 ↗ |
| Known as | NSC-26256 | ChEMBL registry synonym — accepted as the source's own label CHEMBL46730 ↗ |
| Known as | Ravatite | ChEMBL registry synonym — accepted as the source's own label CHEMBL46730 ↗ |
| Modality | Small molecule | — CHEMBL46730 ↗ |
| Route | Oral | “following oral doses of 50 ng dose (5.4 nCi) alone or with 1250 ng phenanthrene” NCT03631667 ↗ |